Business
줄기세포 치료제
CDMO 사업
R&D
보유기술
강스템바이오텍은 세포치료제와 오가노이드 기반 플랫폼 기술을 중심으로 과학적 검증과 임상적 가능성을 동시에 갖춘 혁신 치료제를 개발하고 있습니다.
Therapeutic Effects of Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells Combined with Cartilage Acellular Matrix Mediated Via Bone Morphogenic Protein 6 in a Rabbit Model of Articular Cruciate Ligament Transection
01
2020.06
Title | Therapeutic Effects of Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells Combined with Cartilage Acellular Matrix Mediated Via Bone Morphogenic Protein 6 in a Rabbit Model of Articular Cruciate Ligament Transection |
Title (ISO) | Stem Cell Rev Rep |
Title (JCR Abbrev.) | STEM CELL REV REP |
Title (Full name) | Stem Cell Reviews and Reports |
출판사 | HUMANA PRESS INC |
게재년월 | 2020.06 |
ISSN | 1550-8943 |
SCI | SCIE |
Author | Hyo-Jin Jeon, Kyung-Ae Yoon, Eun Suk An, Tae-Wook Kang, Yun-Beom Sim, Jongchan Ahn, Ehn-Kyung Choi, Seunghee Lee, Kwang-Won Seo, Yun-Bae Kim, Kyung-Sun Kang |
총저자수 | 11 |
국가개발연구 과제 |
|
제1저자 | 전효진 |
논문보기 |
줄기세포 치료제
CDMO 사업
보유기술